Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798553/
https://www.ncbi.nlm.nih.gov/pubmed/29443320
http://dx.doi.org/10.2147/IJN.S162136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798553/
https://www.ncbi.nlm.nih.gov/pubmed/29443320
http://dx.doi.org/10.2147/IJN.S162136

Ejemplares similares